Cytosorbents Corp (CTSO) stock
CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$4.52−0.33 (-6.80%)
Close on Nov 17, 2026Market cap $284.05MP/E –Yield –
Cytosorbents operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cytosorbents's operating cash flow for the twelve months ending Jun 30, 2026 was -$9.15M. For fiscal 2025 it was -$12.38M. The highest annual figure on record is -$2.48M in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$12.38M | – |
| FY2024 | Dec 31, 2024 | -$14.43M | – |
| FY2023 | Dec 31, 2023 | -$21.66M | – |
| FY2022 | Dec 31, 2022 | -$28.23M | – |
| FY2021 | Dec 31, 2021 | -$14.01M | – |
| FY2020 | Dec 31, 2020 | -$5.61M | – |
| FY2019 | Dec 31, 2019 | -$16.76M | – |
| FY2018 | Dec 31, 2018 | -$10.84M | – |
| FY2017 | Dec 31, 2017 | -$6.46M | – |
| FY2016 | Dec 31, 2016 | -$6.73M | – |
| FY2015 | Dec 31, 2015 | -$9.05M | – |
| FY2014 | Dec 31, 2014 | -$6.28M | – |
| FY2013 | Dec 31, 2013 | -$3.49M | – |
| FY2012 | Dec 31, 2012 | -$3.62M | – |
| FY2011 | Dec 31, 2011 | -$3.83M | – |
| FY2010 | Dec 31, 2010 | -$2.48M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$583.00K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.16M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.83M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.58M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.51M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.47M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.34M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.46M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.79M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.83M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.41M | – |
| Q3 FY2023 | Sep 30, 2023 | -$5.21M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.93M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.11M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.34M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.73M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.04M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.12M | – |
| Q4 FY2021 | Dec 31, 2021 | -$5.49M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.13M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.04M | -205.1% |
| Q1 FY2021 | Mar 31, 2021 | -$2.34M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.06M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.28M | – |
| Q2 FY2020 | Jun 30, 2020 | $1.94M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.21M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.12M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.21M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.19M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.24M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.71M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.64M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.29M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.20M | – |
| Q4 FY2017 | Dec 31, 2017 | -$409.48K | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.18M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.88M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.98M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.08M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.47M | – |
See a number that looks wrong?